HomePoultryMexico Reevaluates H5N1 Clade 2.3.4.4b Poultry Vaccines to Upgrade Biosecurity

Mexico Reevaluates H5N1 Clade 2.3.4.4b Poultry Vaccines to Upgrade Biosecurity

MEXICO CITY, Mexico — October 15, 2026 — Mexico’s National Service for Health, Food Safety and Quality (SENASICA), alongside international virology researchers, has released updated efficacy evaluations of commercial avian influenza vaccines targeting High Pathogenicity Avian Influenza (HPAI) A(H5N1) clade 2.3.4.4b. The findings outline a updated strategy for ring-vaccination across high-density commercial egg-layer and broiler zones in Jalisco, Guanajuato, and Puebla.

Evaluating Cellular and Neutralizing Antibody Correlates

Published research evaluates both neutralizing antibody titers and non-neutralizing cellular immune markers driven by updated commercial H5 recombinant vaccines:

  • Clade-Specific Protection: Bivalent formulations matching circulating Latin American 2.3.4.4b wild-bird isolates demonstrated complete suppression of viral shedding in commercial poultry challenge models.

  • Systemic Surveillance Protocols: SENASICA mandates that vaccinated commercial flocks undergo routine sentinel bird monitoring to differentiate infected from vaccinated animals (DIVA strategy), safeguarding international poultry trade agreements.

Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES